{"DataElement":{"publicId":"6662980","version":"1","preferredName":"Primary Tumor Histologic Variation Classification Category","preferredDefinition":"Information related to the histologic variation classification category of a primary tumor.","longName":"6662815v1.0:6662964v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"6662815","version":"1","preferredName":"Primary Neoplasm Histologic Variation Classification","preferredDefinition":"A tumor at the original site of origin._Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._An alteration or difference from a norm or standard._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"6662812v1.0:6662813v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"2721570","version":"1","preferredName":"Primary Neoplasm","preferredDefinition":"The original tumor.","longName":"C8509","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Neoplasm","conceptCode":"C8509","definition":"A tumor at the original site of origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43DA027B-D5CB-0730-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-16","modifiedBy":"ONEDATA","dateModified":"2008-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6675585","version":"1","preferredName":"Histologic Variation Classification","preferredDefinition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.:An alteration or difference from a norm or standard.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"C25526:C25713:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Variation","conceptCode":"C25713","definition":"An alteration or difference from a norm or standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84109F26-A29C-4E6B-E053-F662850A85DE","latestVersionIndicator":"Yes","beginDate":"2019-03-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-14","modifiedBy":"ONEDATA","dateModified":"2019-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8386AD5A-EA7E-0381-E053-F662850A598A","latestVersionIndicator":"Yes","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-07","modifiedBy":"MORENOC","dateModified":"2019-11-04","changeDescription":"11/4/2019: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6662964","version":"1","preferredName":"Primary Tumor Histologic Variation Category","preferredDefinition":"A grouping of items based on some commonality or by user defined characteristics related to the histologic variation of a primary tumor.","longName":"6662964v1.0","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849E68D7-A524-5DF2-E053-F662850A0783","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"Bone cancer only","valueDescription":"Malignant Bone Neoplasm Single","ValueMeaning":{"publicId":"6675081","version":"1","preferredName":"Malignant Bone Neoplasm Single","longName":"6675081","preferredDefinition":"A primary or metastatic malignant neoplasm affecting the bone or articular cartilage.: Not accompanied by another or others; exclusive of anyone or anything else.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Bone Neoplasm","conceptCode":"C4016","definition":"A primary or metastatic malignant neoplasm affecting the bone or articular cartilage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Single","conceptCode":"C48440","definition":"Not accompanied by another or others; exclusive of anyone or anything else.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8410ACA6-68A5-7CDB-E053-F662850AC7AE","latestVersionIndicator":"Yes","beginDate":"2019-03-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-14","modifiedBy":"ONEDATA","dateModified":"2019-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8410ACA6-68BE-7CDB-E053-F662850AC7AE","beginDate":"2019-03-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-14","modifiedBy":"ONEDATA","dateModified":"2019-03-14","deletedIndicator":"No"},{"value":"Small cell carcinoma of the bladder","valueDescription":"Bladder Small Cell Carcinoma","ValueMeaning":{"publicId":"6662968","version":"1","preferredName":"Bladder Small Cell Carcinoma","longName":"6662968","preferredDefinition":"A highly aggressive carcinoma, histologically resembling small cell lung carcinoma.  In most cases it is associated with carcinoma in situ.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Small Cell Neuroendocrine Carcinoma","conceptCode":"C9461","definition":"A small cell neuroendocrine carcinoma arising from the bladder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"838734B3-871C-03A4-E053-F662850A5CE4","latestVersionIndicator":"Yes","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-07","modifiedBy":"ONEDATA","dateModified":"2019-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8410ACA6-68D4-7CDB-E053-F662850AC7AE","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-14","modifiedBy":"ONEDATA","dateModified":"2019-03-14","deletedIndicator":"No"},{"value":"Adenocarcinoma of the bladder","valueDescription":"Bladder Adenocarcinoma","ValueMeaning":{"publicId":"6662970","version":"1","preferredName":"Bladder Adenocarcinoma","longName":"6662970","preferredDefinition":"A rare adenocarcinoma arising from metaplastic bladder epithelium.  It is frequently associated with long-standing local irritation.  The majority of cases originate from the trigone and the posterior wall of the bladder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Adenocarcinoma","conceptCode":"C4032","definition":"A rare adenocarcinoma arising from metaplastic bladder epithelium. It is frequently associated with long-standing local irritation. The majority of cases originate from the trigone and the posterior wall of the bladder. This group does not include clear cell and endometrioid adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"838734B3-8742-03A4-E053-F662850A5CE4","latestVersionIndicator":"Yes","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-07","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8410ACA6-68EA-7CDB-E053-F662850AC7AE","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-14","modifiedBy":"ONEDATA","dateModified":"2019-03-14","deletedIndicator":"No"},{"value":"Squamous cell carcinoma of the bladder","valueDescription":"Bladder Squamous Cell Carcinoma","ValueMeaning":{"publicId":"6662972","version":"1","preferredName":"Bladder Squamous Cell Carcinoma","longName":"6662972","preferredDefinition":"A squamous cell carcinoma of the bladder arising from metaplastic epithelium.  It represents less than 10% of bladder carcinomas.  The exception is the Middle East along the Nile Valley, where it represents the most common form of carcinoma because of the endemic nature of schistosomiasis.  Bladder squamous cell carcinoma is often associated with long-standing chronic inflammation of the bladder and usually has a poor prognosis.  The diagnosis of squamous cell carcinoma of the bladder should be reserved for those tumors that are predominantly keratin forming.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Squamous Cell Carcinoma","conceptCode":"C4031","definition":"A squamous cell carcinoma of the bladder arising from metaplastic epithelium.  It represents less than 10% of bladder carcinomas.  The exception is the Middle East along the Nile Valley, where it represents the most common form of carcinoma because of the endemic nature of schistosomiasis.  Bladder squamous cell carcinoma is often associated with long-standing chronic inflammation of the bladder and usually has a poor prognosis.  The diagnosis of squamous cell carcinoma of the bladder should be reserved for those tumors that are predominantly keratin forming.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"838734B3-8768-03A4-E053-F662850A5CE4","latestVersionIndicator":"Yes","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-07","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8410ACA6-6900-7CDB-E053-F662850AC7AE","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-14","modifiedBy":"ONEDATA","dateModified":"2019-03-14","deletedIndicator":"No"},{"value":"Plasmacytoid urothelial carcinoma of the bladder","valueDescription":"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant","ValueMeaning":{"publicId":"6662974","version":"1","preferredName":"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant","longName":"6662974","preferredDefinition":"A variant of infiltrating bladder urothelial carcinoma. It is characterized by plasmacytoid-like features.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Bladder Plasmacytoid Urothelial Carcinoma","conceptCode":"C39823","definition":"Invasive bladder urothelial carcinoma characterized by the presence of malignant cells with plasmacytoid features.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"838734B3-878E-03A4-E053-F662850A5CE4","latestVersionIndicator":"Yes","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-07","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8410ACA6-6916-7CDB-E053-F662850AC7AE","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-14","modifiedBy":"ONEDATA","dateModified":"2019-03-14","deletedIndicator":"No"},{"value":"Penile cancer","valueDescription":"Penile Carcinoma","ValueMeaning":{"publicId":"4722582","version":"1","preferredName":"Penile Carcinoma","longName":"4722582","preferredDefinition":"A carcinoma that arises from the penis. Risk factors include phimosis and human papillomavirus infection. The majority of penile carcinomas are squamous cell carcinomas. The most frequent clinical presentation is an irregular mass in the glans of the penis. Treatment includes surgical management and radiation therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Penile Carcinoma","conceptCode":"C9061","definition":"A carcinoma that arises from the penis. Risk factors include phimosis and human papillomavirus infection. The majority of penile carcinomas are squamous cell carcinomas. The most frequent clinical presentation is an irregular mass in the glans of the penis. Treatment includes surgical management and radiation therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B916-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8410ACA6-692C-7CDB-E053-F662850AC7AE","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-14","modifiedBy":"ONEDATA","dateModified":"2019-03-14","deletedIndicator":"No"},{"value":"Sarcomatoid renal cell carcinoma","valueDescription":"Sarcomatoid Renal Cell Carcinoma","ValueMeaning":{"publicId":"2581627","version":"1","preferredName":"Sarcomatoid Renal Cell Carcinoma","longName":"2581627","preferredDefinition":"A high grade carcinoma of the kidney.  It is not a distinct clinicopathological entity and includes a diverse group of renal cell carcinomas which have been transformed from a lower to a higher grade.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcomatoid Renal Cell Carcinoma","conceptCode":"C27893","definition":"A high grade carcinoma of the kidney.  It is not a distinct clinicopathological entity and includes a diverse group of renal cell carcinomas which have been transformed from a lower to a higher grade.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0BE8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-07","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-07","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8410ACA6-6942-7CDB-E053-F662850AC7AE","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-14","modifiedBy":"ONEDATA","dateModified":"2019-03-14","deletedIndicator":"No"},{"value":"Miscellaneous GU tract histologic variants","valueDescription":"Miscellaneous Genitourinary Histologic Variation","ValueMeaning":{"publicId":"6662975","version":"1","preferredName":"Miscellaneous Genitourinary Histologic Variation","longName":"6662975","preferredDefinition":"Diverse, mixed, consisting of an assortment of different kinds.: Of or related to the genital and urinary organs or their functions.: Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.: An alteration or difference from a norm or standard.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Miscellaneous","conceptCode":"C69023","definition":"Diverse, mixed, consisting of an assortment of different kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Genitourinary","conceptCode":"C25350","definition":"Of or related to the genital and urinary organs or their functions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Variation","conceptCode":"C25713","definition":"An alteration or difference from a norm or standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"838734B3-87DE-03A4-E053-F662850A5CE4","latestVersionIndicator":"Yes","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-07","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8410ACA6-6958-7CDB-E053-F662850AC7AE","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-14","modifiedBy":"ONEDATA","dateModified":"2019-03-14","deletedIndicator":"No"},{"value":"Sarcomatoid urothelial carcinoma of the bladder","valueDescription":"Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant","ValueMeaning":{"publicId":"6662976","version":"1","preferredName":"Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant","longName":"6662976","preferredDefinition":"An invasive transitional cell carcinoma of the bladder that exhibits spindle cell sarcomatoid features.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Bladder Sarcomatoid Urothelial Carcinoma","conceptCode":"C39824","definition":"An invasive urothelial carcinoma of the bladder that exhibits spindle cell sarcomatoid features.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"838734B3-8803-03A4-E053-F662850A5CE4","latestVersionIndicator":"Yes","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-07","modifiedBy":"ONEDATA","dateModified":"2019-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8410ACA6-696E-7CDB-E053-F662850AC7AE","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-14","modifiedBy":"ONEDATA","dateModified":"2019-03-14","deletedIndicator":"No"},{"value":"Renal medullary carcinoma","valueDescription":"Kidney Medullary Carcinoma","ValueMeaning":{"publicId":"5210416","version":"1","preferredName":"Kidney Medullary Carcinoma","longName":"5210416","preferredDefinition":"A recently described type of renal carcinoma, affecting mostly young African-Americans.  It is located in the medulla of the kidney, and follows an aggressive clinical course.  Most reported cases have shown metastatic disease at the time of diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Medullary Carcinoma","conceptCode":"C7572","definition":"A type of renal carcinoma affecting mostly young African-Americans.  It is located in the medulla of the kidney, and follows an aggressive clinical course.  Most reported cases have shown metastatic disease at the time of diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB1364C-656F-8128-E050-BB89AD436BE4","latestVersionIndicator":"Yes","beginDate":"2016-04-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8410ACA6-697A-7CDB-E053-F662850AC7AE","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-14","modifiedBy":"ONEDATA","dateModified":"2019-03-14","deletedIndicator":"No"},{"value":"Renal, collecting duct carcinoma","valueDescription":"Carcinoma of the Collecting Ducts of Bellini","ValueMeaning":{"publicId":"2581666","version":"1","preferredName":"Carcinoma of the Collecting Ducts of Bellini","longName":"2581666","preferredDefinition":"Also known as collecting duct carcinoma, this is a rare type of renal carcinoma. It arises from the collecting ducts of the renal medulla, and most authors suggest that this is an aggressive tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Collecting Duct Carcinoma","conceptCode":"C6194","definition":"Also known as collecting duct carcinoma, this is a rare type of renal carcinoma. It arises from the collecting ducts of the renal medulla, and most authors suggest that this is an aggressive tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C0F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-09","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-09","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849D7108-9DF9-203E-E053-F662850A6E02","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"Sertoli cell tumor or Leydig cell tumor","valueDescription":"Sertoli Cell Tumor Or Leydig Cell Tumor","ValueMeaning":{"publicId":"6680078","version":"1","preferredName":"Sertoli Cell Tumor Or Leydig Cell Tumor","longName":"6680078","preferredDefinition":"A sex cord-stromal tumor of the testis or the ovary. It is characterized by the presence of Sertoli cells forming tubules. Leydig cells are rare or absent. It may be associated with Peutz-Jeghers syndrome. In males, the presenting symptom is a slow growing testicular mass. Most cases follow a benign clinical course. In females it may present with estrogenic or androgenic manifestations. The vast majority of cases have a benign clinical course.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A sex cord-stromal tumor occurring in the testis and rarely in the ovary. It is predominantly or completely composed of Leydig cells which may contain crystals of Reinke. In males it usually presents as a painless testicular enlargement and it may be associated with gynecomastia and decreased libido. The majority of the cases have a benign clinical course. Approximately 10% of the cases have a malignant clinical course and metastasize. In females it may be associated with androgenic manifestations and it follows a benign clinical course.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sertoli Cell Tumor","conceptCode":"C39976","definition":"A sex cord-stromal tumor of the testis or the ovary. It is characterized by the presence of Sertoli cells forming tubules. Leydig cells are rare or absent. It may be associated with Peutz-Jeghers syndrome. In males, the presenting symptom is a slow growing testicular mass. Most cases follow a benign clinical course. In females it may present with estrogenic or androgenic manifestations. The vast majority of cases have a benign clinical course.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Leydig Cell Tumor","conceptCode":"C3188","definition":"A sex cord-stromal tumor occurring in the testis and rarely in the ovary. It is predominantly or completely composed of Leydig cells which may contain crystals of Reinke. In males it usually presents as a painless testicular enlargement and it may be associated with gynecomastia and decreased libido. The majority of the cases have a benign clinical course. Approximately 10% of the cases have a malignant clinical course and metastasize. In females it may be associated with androgenic manifestations and it follows a benign clinical course.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849D7108-9E07-203E-E053-F662850A6E02","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849D7108-9E20-203E-E053-F662850A6E02","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"Prostate small (neuroendocrine) cell carcinoma","valueDescription":"Prostate Small Cell Carcinoma","ValueMeaning":{"publicId":"2581148","version":"1","preferredName":"Prostate Small Cell Carcinoma","longName":"2581148","preferredDefinition":"A neuroendocrine carcinoma of the prostate gland with unfavorable prognosis. It is composed of small cells containing neurosecretory granules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Small Cell Neuroendocrine Carcinoma","conceptCode":"C6766","definition":"A rare small cell neuroendocrine carcinoma that arises from the prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A09-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849D7108-9E34-203E-E053-F662850A6E02","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"Chromophobe renal cell carcinoma","valueDescription":"Chromophobe Renal Cell Carcinoma","ValueMeaning":{"publicId":"5118714","version":"1","preferredName":"Chromophobe Renal Cell Carcinoma","longName":"5118714","preferredDefinition":"A type of carcinoma that comprises a minority of renal cell carcinomas.  It is characterized by loss of chromosomes 1 and Y.  Based on the cytoplasmic characteristics of the neoplastic cells, this type of carcinoma is classified as classic (typical) or eosinophilic.  It has a much better prognosis than other renal cell carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chromophobe Renal Cell Carcinoma","conceptCode":"C4146","definition":"A type of carcinoma that comprises a minority of renal cell carcinomas.  It is characterized by loss of chromosomes 1 and Y.  Based on the cytoplasmic characteristics of the neoplastic cells, this type of carcinoma is classified as classic (typical), eosinophilic, or oncocytic.  It has a much better prognosis than other renal cell carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AFC3522-397C-B863-E050-BB89AD4335E0","latestVersionIndicator":"Yes","beginDate":"2016-02-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-04","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849D7108-9E49-203E-E053-F662850A6E02","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"Penile cancer, squamous cell carcinoma","valueDescription":"Squamous Cell Carcinoma of the Penis","ValueMeaning":{"publicId":"4722584","version":"1","preferredName":"Squamous Cell Carcinoma of the Penis","longName":"4722584","preferredDefinition":"A squamous cell carcinoma arising from the penis.  It occurs chiefly in the squamous epithelium of the glans, coronal sulcus, and foreskin.  Etiologic factors include phimosis, lichen sclerosus, smoking, ultraviolet irradiation, history of warts or condylomas, and lack of circumcision.  Human papilloma virus is present in a subset of penile squamous cell carcinomas.  Patients may present with an exophytic or flat ulcerative mass in the glans or a large primary tumor with inguinal nodal and skin metastases.  Morphologic variants include the basaloid carcinoma, warty (condylomatous) carcinoma, verrucous carcinoma, and sarcomatoid (spindle cell) carcinoma. (WHO, 2004)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Penile Squamous Cell Carcinoma","conceptCode":"C7729","definition":"A squamous cell carcinoma arising from the penis.  It occurs chiefly in the squamous epithelium of the glans, coronal sulcus, and foreskin.  Etiologic factors include phimosis, lichen sclerosus, smoking, ultraviolet irradiation, history of warts or condylomas, and lack of circumcision.  Human papilloma virus is present in a subset of penile squamous cell carcinomas.  Patients may present with an exophytic or flat ulcerative mass in the glans or a large primary tumor with inguinal nodal and skin metastases. (WHO, 2004)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B93C-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849D7108-9E5D-203E-E053-F662850A6E02","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"Lymphoepithelioma-like carcinoma of the bladder","valueDescription":"Infiltrating Bladder Lymphoepithelioma-Like Carcinoma","ValueMeaning":{"publicId":"6680080","version":"1","preferredName":"Infiltrating Bladder Lymphoepithelioma-Like Carcinoma","longName":"6680080","preferredDefinition":"Infiltrating carcinoma with lymphoepithelioma-like features that affects the bladder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Bladder Lymphoepithelioma-Like Carcinoma","conceptCode":"C39821","definition":"Invasive bladder urothelial carcinoma with lymphoepithelioma-like features.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849D7108-9E6A-203E-E053-F662850A6E02","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849D7108-9E83-203E-E053-F662850A6E02","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"Large cell neuroendocrine carcinoma of the bladder","valueDescription":"Large Cell Neuroendocrine Carcinoma Bladder","ValueMeaning":{"publicId":"6680081","version":"1","preferredName":"Large Cell Neuroendocrine Carcinoma Bladder","longName":"6680081","preferredDefinition":"A usually aggressive carcinoma composed of large malignant cells which display neuroendocrine characteristics. It is characterized by the presence of high mitotic activity and necrotic changes. The vast majority of cases are positive for neuron-specific enolase. Representative examples include lung, breast, cervical, and thymic neuroendocrine carcinomas.: The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Large Cell Neuroendocrine Carcinoma","conceptCode":"C6875","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant large cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Bladder","conceptCode":"C12414","definition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849D7108-9E90-203E-E053-F662850A6E02","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849D7108-9EA9-203E-E053-F662850A6E02","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"Clear cell adenocarcinoma of the bladder","valueDescription":"Bladder Clear Cell Adenocarcinoma","ValueMeaning":{"publicId":"3248216","version":"1","preferredName":"Bladder Clear Cell Adenocarcinoma","longName":"3248216","preferredDefinition":"A rare morphologic variant of bladder adenocarcinoma characterized by the presence of malignant glandular epithelial cells and clear cells distributed in a tubulo-cystic, papillary, or diffuse pattern.  There is a female predilection.  Clinical presentation includes hematuria and dysuria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Clear Cell Adenocarcinoma","conceptCode":"C6179","definition":"A bladder adenocarcinoma characterized by the presence of malignant glandular epithelial cells and clear cells distributed in a tubulo-cystic, papillary, or diffuse pattern. There is a female predilection. Clinical presentation includes hematuria and dysuria.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B537E2-8019-5E57-E040-BB89AD4339B4","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849D7108-9EBD-203E-E053-F662850A6E02","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"Lipid-rich carcinoma","valueDescription":"Lipid-Rich Carcinoma","ValueMeaning":{"publicId":"3669456","version":"1","preferredName":"Lipid-Rich Carcinoma","longName":"3669456","preferredDefinition":"A carcinoma characterized by the presence of malignant epithelial cells with clear cytoplasm which contains neutral lipids. A representative example is the lipid-rich breast carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lipid-Rich Carcinoma","conceptCode":"C4152","definition":"A carcinoma characterized by the presence of malignant epithelial cells with clear cytoplasm which contains neutral lipids. A representative example is the lipid-rich breast carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7788-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849D7108-9EC7-203E-E053-F662850A6E02","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"Giant cell carcinoma","valueDescription":"Giant Cell Carcinoma","ValueMeaning":{"publicId":"4264813","version":"1","preferredName":"Giant Cell Carcinoma","longName":"4264813","preferredDefinition":"A malignant epithelial neoplasm composed of giant, pleomorphic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Giant Cell Carcinoma","conceptCode":"C3779","definition":"A malignant epithelial neoplasm composed of giant, pleomorphic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67A42EF-FC0F-5F77-E040-BB89AD433177","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849D7108-9ED2-203E-E053-F662850A6E02","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"Sarcomatoid carcinoma","valueDescription":"Sarcomatoid Carcinoma","ValueMeaning":{"publicId":"2838764","version":"1","preferredName":"Sarcomatoid Carcinoma","longName":"2838764","preferredDefinition":"Cancer that arises in cells that appear spindle-shaped when viewed under a microscope. These cancers can occur in various places in the body, including the skin, lungs, kidney, breast, gastrointestinal tract, bone, and muscle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcomatoid Carcinoma","conceptCode":"C27004","definition":"A malignant epithelial neoplasm characterized by the presence of spindle cells and anaplastic morphologic features.  Giant cells and a sarcomatous component may also be present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-12DF-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849D7108-9EDD-203E-E053-F662850A6E02","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"Adenocarcinoma of the bladder or urachal","valueDescription":"Bladder Adenocarcinoma Or Bladder Urachal Adenocarcinoma","ValueMeaning":{"publicId":"6680083","version":"1","preferredName":"Bladder Adenocarcinoma Or Bladder Urachal Adenocarcinoma","longName":"6680083","preferredDefinition":"A rare adenocarcinoma arising from metaplastic bladder epithelium.  It is frequently associated with long-standing local irritation.  The majority of cases originate from the trigone and the posterior wall of the bladder.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A rare bladder adenocarcinoma that develops from the urachal remnant.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Adenocarcinoma","conceptCode":"C4032","definition":"A rare adenocarcinoma arising from metaplastic bladder epithelium. It is frequently associated with long-standing local irritation. The majority of cases originate from the trigone and the posterior wall of the bladder. This group does not include clear cell and endometrioid adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Urachal Adenocarcinoma","conceptCode":"C39843","definition":"A rare bladder adenocarcinoma that develops from the urachal remnant.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849D7108-9EEC-203E-E053-F662850A6E02","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849D7108-9F05-203E-E053-F662850A6E02","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"Urothelial carcinoma with small cell carcinoma","valueDescription":"Urothelial Carcinoma With Small Cell Carcinoma","ValueMeaning":{"publicId":"6680084","version":"1","preferredName":"Urothelial Carcinoma With Small Cell Carcinoma","longName":"6680084","preferredDefinition":"A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis). It is frequently papillary.: Used to indicate the presence of something or someone.: A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble \"oat cells\" under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urothelial Carcinoma","conceptCode":"C4030","definition":"A carcinoma arising from the urothelial lining of the urinary tract (bladder, renal pelvis, ureter, or urethra).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Small Cell Neuroendocrine Carcinoma","conceptCode":"C3915","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849D7108-9F13-203E-E053-F662850A6E02","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849D7108-9F2C-203E-E053-F662850A6E02","beginDate":"2019-03-21","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"Bone only disease","valueDescription":"Bone Single Disease or Disorder","ValueMeaning":{"publicId":"6780795","version":"1","preferredName":"Bone Single Disease or Disorder","longName":"6780795","preferredDefinition":"Connective tissue that forms the skeletal components of the body.: Not accompanied by another or others; exclusive of anyone or anything else.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone","conceptCode":"C12366","definition":"The structural organ comprised of specialized connective tissue that forms the skeletal components of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Single","conceptCode":"C48440","definition":"Not accompanied by another or others; exclusive of anyone or anything else.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B34FC63-CC84-37F1-E053-F662850A0C70","latestVersionIndicator":"Yes","beginDate":"2019-06-13","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-06-13","modifiedBy":"ONEDATA","dateModified":"2019-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B34FC63-CC9D-37F1-E053-F662850A0C70","beginDate":"2019-06-13","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-06-13","modifiedBy":"ONEDATA","dateModified":"2019-06-13","deletedIndicator":"No"},{"value":"Urothelial carcinoma","valueDescription":"Urothelial Carcinoma","ValueMeaning":{"publicId":"3155848","version":"1","preferredName":"Urothelial Carcinoma","longName":"3155848","preferredDefinition":"A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis).  It is frequently papillary. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urothelial Carcinoma","conceptCode":"C4030","definition":"A carcinoma arising from the urothelial lining of the urinary tract (bladder, renal pelvis, ureter, or urethra).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"943B8AF5-84AC-8068-E040-BB89AD437602","latestVersionIndicator":"Yes","beginDate":"2010-11-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-11-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA09E87B-22F5-6F92-E053-4EBD850A5BCD","beginDate":"2020-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","deletedIndicator":"No"},{"value":"Seminoma","valueDescription":"Seminoma","ValueMeaning":{"publicId":"2986277","version":"1","preferredName":"Seminoma","longName":"2986277","preferredDefinition":"A radiosensitive malignant germ cell tumor found in the testis (especially undescended), and extragonadal sites (anterior mediastinum and pineal gland).  It is characterized by the presence of uniform cells with clear or dense cytoplasm which contains glycogen, and by a large nucleus which contains one or more nucleoli.  The neoplastic germ cells form aggregates separated by fibrous septa.  The fibrous septa contain chronic inflammatory cells, mainly lymphocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Seminoma","conceptCode":"C9309","definition":"A radiosensitive malignant germ cell tumor found in the testis (especially undescended), and extragonadal sites (anterior mediastinum and pineal gland).  It is characterized by the presence of uniform cells with clear or dense cytoplasm which contains glycogen, and by a large nucleus which contains one or more nucleoli.  The neoplastic germ cells form aggregates separated by fibrous septa.  The fibrous septa contain chronic inflammatory cells, mainly lymphocytes.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D112249-863E-E0FD-E040-BB89AD432FCB","latestVersionIndicator":"Yes","beginDate":"2010-01-13","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-01-13","modifiedBy":"ONEDATA","dateModified":"2010-01-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA09E87B-22FF-6F92-E053-4EBD850A5BCD","beginDate":"2020-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","deletedIndicator":"No"},{"value":"Renal cell carcinoma","valueDescription":"Renal Cell Carcinoma","ValueMeaning":{"publicId":"3248535","version":"1","preferredName":"Renal Cell Carcinoma","longName":"3248535","preferredDefinition":"Cancer that develops in the lining of the renal tubules, which filter the blood and produce urine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Cell Carcinoma","conceptCode":"C9385","definition":"A carcinoma arising from the renal parenchyma.  There is a strong correlation between cigarette smoking and the development of renal cell carcinoma.  The clinical presentation includes : hematuria, flank pain and a palpable lumbar mass.  A high percentage of renal cell carcinomas are diagnosed when an ultrasound is performed for other purposes.  Radical nephrectomy is the standard intervention procedure.  Renal cell carcinoma is generally considered to be resistant to radiation treatment and chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-BA15-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA09E87B-2313-6F92-E053-4EBD850A5BCD","beginDate":"2020-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","deletedIndicator":"No"},{"value":"Papillary","valueDescription":"Papillary Carcinoma","ValueMeaning":{"publicId":"4264950","version":"1","preferredName":"Papillary Carcinoma","longName":"4264950","preferredDefinition":"A malignant epithelial neoplasm characterized by a papillary growth pattern. A papillary carcinoma may be composed of glandular cells (papillary adenocarcinoma), squamous cells (papillary squamous cell carcinoma), or transitional cells (papillary transitional cell carcinoma). Bladder carcinoma is a representative example of papillary transitional cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Carcinoma","conceptCode":"C2927","definition":"A malignant epithelial neoplasm characterized by a papillary growth pattern. A papillary carcinoma may be composed of glandular cells (papillary adenocarcinoma), squamous cells (papillary squamous cell carcinoma), or transitional cells (papillary transitional cell carcinoma). Bladder carcinoma is a representative example of papillary transitional cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3955-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA09E87B-231D-6F92-E053-4EBD850A5BCD","beginDate":"2020-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","deletedIndicator":"No"},{"value":"Non-seminoma","valueDescription":"Non-seminoma","ValueMeaning":{"publicId":"4512192","version":"1","preferredName":"Non-seminoma","longName":"4512192","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: A radiosensitive malignant germ cell tumor found in the testis (especially undescended), and extragonadal sites (anterior mediastinum and pineal gland).  It is characterized by the presence of uniform cells with clear or dense cytoplasm which contains glycogen, and by a large nucleus which contains one or more nucleoli.  The neoplastic germ cells form aggregates separated by fibrous septa.  The fibrous septa contain chronic inflammatory cells, mainly lymphocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Seminoma","conceptCode":"C9309","definition":"A radiosensitive malignant germ cell tumor found in the testis (especially undescended), and extragonadal sites (anterior mediastinum and pineal gland).  It is characterized by the presence of uniform cells with clear or dense cytoplasm which contains glycogen, and by a large nucleus which contains one or more nucleoli.  The neoplastic germ cells form aggregates separated by fibrous septa.  The fibrous septa contain chronic inflammatory cells, mainly lymphocytes.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04C486F7-E8F1-DFC8-E050-BB89AD4363E2","latestVersionIndicator":"Yes","beginDate":"2014-10-06","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-10-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA09E87B-2328-6F92-E053-4EBD850A5BCD","beginDate":"2020-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","deletedIndicator":"No"},{"value":"Nested variants","valueDescription":"Infiltrating Bladder Urothelial Carcinoma, Nested Variant","ValueMeaning":{"publicId":"7350594","version":"1","preferredName":"Infiltrating Bladder Urothelial Carcinoma, Nested Variant","longName":"7350594","preferredDefinition":"A variant of infiltrating bladder urothelial carcinoma. It is characterized by a nested growth pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Bladder Nested Urothelial Carcinoma","conceptCode":"C39819","definition":"Invasive bladder urothelial carcinoma characterized by a nested growth pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA09E87B-2336-6F92-E053-4EBD850A5BCD","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA09E87B-234F-6F92-E053-4EBD850A5BCD","beginDate":"2020-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","deletedIndicator":"No"},{"value":"Micropapillary variant of urothelial carcinoma","valueDescription":"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant","ValueMeaning":{"publicId":"7350596","version":"1","preferredName":"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant","longName":"7350596","preferredDefinition":"An infiltrating bladder transitional cell carcinoma exhibiting micropapillary growth pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Bladder Micropapillary Urothelial Carcinoma","conceptCode":"C27202","definition":"An invasive bladder urothelial carcinoma exhibiting micropapillary growth pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA09E87B-235C-6F92-E053-4EBD850A5BCD","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA09E87B-2375-6F92-E053-4EBD850A5BCD","beginDate":"2020-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","deletedIndicator":"No"},{"value":"Urethral carcinoma","valueDescription":"Urethral Carcinoma","ValueMeaning":{"publicId":"6832786","version":"1","preferredName":"Urethral Carcinoma","longName":"6832786","preferredDefinition":"A carcinoma that arises from the urethra. Morphologically, the tumors are similar to those described in the bladder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urethral Carcinoma","conceptCode":"C9106","definition":"A carcinoma that arises from the urethra. Morphologically, the tumors are similar to those described in the bladder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E9B6DDA-07C7-7758-E053-F662850A2630","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B79F3683-419E-2F7B-E053-4EBD850A253D","beginDate":"2020-12-29","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-12-29","modifiedBy":"ONEDATA","dateModified":"2020-12-29","deletedIndicator":"No"},{"value":"Renal collecting duct carcinoma","valueDescription":"Carcinoma of the Collecting Ducts of Bellini","ValueMeaning":{"publicId":"2581666","version":"1","preferredName":"Carcinoma of the Collecting Ducts of Bellini","longName":"2581666","preferredDefinition":"Also known as collecting duct carcinoma, this is a rare type of renal carcinoma. It arises from the collecting ducts of the renal medulla, and most authors suggest that this is an aggressive tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Collecting Duct Carcinoma","conceptCode":"C6194","definition":"Also known as collecting duct carcinoma, this is a rare type of renal carcinoma. It arises from the collecting ducts of the renal medulla, and most authors suggest that this is an aggressive tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C0F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-09","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-09","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B79F3683-41B2-2F7B-E053-4EBD850A253D","beginDate":"2020-12-29","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-12-29","modifiedBy":"ONEDATA","dateModified":"2020-12-29","deletedIndicator":"No"},{"value":"Small cell/neuroendocrine carcinoma of the bladder","valueDescription":"Bladder Small Cell Carcinoma Neuroendocrine Carcinoma Bladder","ValueMeaning":{"publicId":"7540025","version":"1","preferredName":"Bladder Small Cell Carcinoma Neuroendocrine Carcinoma Bladder","longName":"7540025","preferredDefinition":"A highly aggressive carcinoma, histologically resembling small cell lung carcinoma.  In most cases it is associated with carcinoma in situ.: A malignant epithelial neoplasm with neuroendocrine differentiation.: The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Small Cell Neuroendocrine Carcinoma","conceptCode":"C9461","definition":"A small cell neuroendocrine carcinoma arising from the bladder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neuroendocrine Carcinoma","conceptCode":"C3773","definition":"A usually aggressive carcinoma composed of malignant cells exhibiting neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Bladder","conceptCode":"C12414","definition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B79F3683-41C0-2F7B-E053-4EBD850A253D","latestVersionIndicator":"Yes","beginDate":"2020-12-29","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-12-29","modifiedBy":"ONEDATA","dateModified":"2020-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B79F3683-41D9-2F7B-E053-4EBD850A253D","beginDate":"2020-12-29","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-12-29","modifiedBy":"ONEDATA","dateModified":"2020-12-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"838734B3-86E8-03A4-E053-F662850A5CE4","latestVersionIndicator":"Yes","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-07","modifiedBy":"MORENOC","dateModified":"2020-12-29","changeDescription":"11/4/2019: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[{"name":"CCR","type":"USED_BY","context":"CCR"}],"ReferenceDocuments":[{"name":"Primary Histology","type":"Preferred Question Text","description":"Primary Histology","url":null,"context":"Alliance"},{"name":"C3D Question Text","type":"Alternate Question Text","description":"PRIMARY HISTOLOGY","url":null,"context":"CCR"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8386531A-39AB-040B-E053-F662850A7213","latestVersionIndicator":"Yes","beginDate":"2019-03-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-07","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":"11/4/2019: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}